Efficacy of Raltegravir monotherapy and in combination with Etravirine in patient with virological failure and treatment-experienced but had not previously received RAL or another integrase strand-transfer inhibitor.
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Etravirine (Primary) ; Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 21 Sep 2017 New trial record
- 01 Aug 2017 Results assessing efficacy of raltegravir as monotherapy and in combination with etravirine in patient with virological failure and treatment-experienced but had not previously received RAL or another integrase strand-transfer inhibitor, were published in the JAIDS.